Since ANGPT2, a miR-1 target, is a biomarker of lung dysfunction in patients with septic shock and ARDS (27, 30–33), we performed an exploratory study to assess the clinical relevance of miR-1. This evidence concerns the gene ANGPT2 and acute respiratory distress syndrome.